LONDON (Alliance News) - AstraZeneca PLC hit back at US drugsmaker Pfizer Inc Tuesday, saying that it believes it is "making an opportunistic attempt to acquire a transformed AstraZeneca, without reflecting the value of its exciting pipeline." The company noted Pfizer's statement Tuesday re Read More
LONDON (Alliance News) - The following is a summary of top news stories Tuesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>AstraZeneca</strong> PLC announced positive results from its late-stage study of combination treatment saxagliptin and dapagliflozin for Read More
LONDON (Alliance News) - AstraZeneca PLC Tuesday announced positive results from its late-stage study of combination treatment saxagliptin and dapagliflozin for the treatment of type 2 diabetes, for patients whose condition was no adequately controlled by the generic diabetes drug metformin. < Read More
LONDON (Alliance News) - Mid-cap stocks are leading London equities higher at the open Tuesday, following a strong lead in from the US and Asia, particularly Tokyo.<br /><br /><strong>Taylor Wimpey</strong> is leading the mid-cap FTSE 250, up 5.7%, after saying it expects to deliver a big incr Read More
LONDON (Alliance News) - UK stocks are expected to continue their push higher Tuesday, as investors take their cues from another strong close on Wall Street on Monday and a largely positive Asian session overnight. Following a firmly positive close in Europe on Monday, US stocks pushed sign Read More
LONDON (Alliance News) - US pharmaceutical giant Pfizer Inc. is planning to raise its bid for British rival AstraZeneca PLC a second time before it considers whether to make a hostile bid, Bloomberg reported Monday, citing people with knowledge of the matter. According to the Bloomberg repo Read More
LONDON (Alliance News) - AstraZeneca PLC Monday announced a flurry of positive data from mid-stage trials from its biological research and development arm MedImmune's respiratory, inflammation and autoimmune portfolio. Both rheumatoid arthritis treatment mavrilimumab and lupus treatment sif Read More
(An item published at 1221 GMT misstated the day of the evidence hearing. The correction version follows.) LONDON (Alliance News) - US drugmaker Pfizer Inc continued its campaign to buy FTSE 100 drugmaker AstraZeneca PLC Monday, submitting a statement to the UK House of Commons. Pfize Read More
LONDON (Alliance News) -<strong> British Sky Broadcasting</strong> confirmed Monday that it is working on the potential acquisition of 21st Century Fox's interests in Sky Deutschland and Sky Italia.<br /><br />Bloomberg, citing people familiar with the matter, reported that talks about the pot Read More
LONDON (Alliance News) - US drugmaker Pfizer Inc continued its campaign to buy FTSE 100 drugmaker AstraZeneca PLC Monday, submitting a statement to the UK House of Commons. Pfizer's Chief Executive Ian Read and AstraZeneca's Chief Executive Pascal Soriot will present evidence to the House B Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>British Sky Broadcasting</strong> Group PLC confirmed it is working on the potential acquisition of 21st Century Fox's interests in Sky D Read More
LONDON (Alliance News) - UK shares have opened cautiously higher Monday, amid a lack of economic data and with a wary eye on developments in Ukraine.<br /><br /><strong>BSkyB</strong> confirmed press reports that has approached its major shareholder 21st Century Fox about buying Sky Deutschlan Read More
LONDON (Alliance News) - AstraZeneca PLC and Amgen Inc said Monday that the Phase 3 AMAGINE-1 study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis met all primary and secondary endpoints for both evaluated doses. Brodalumab is the only investigational treatment i Read More
LONDON (Alliance News) - AstraZeneca PLC and Amgen Inc said Monday that the Phase 3 AMAGINE-1 study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis met all primary and secondary endpoints for both evaluated doses. Brodalumab is the only investigational treatment i Read More
LONDON (Alliance News) - AstraZeneca PLC and Amgen Inc said Monday that the Phase 3 AMAGINE-1 study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis met all primary and secondary endpoints for both evaluated doses. Brodalumab is the only investigational treatment i Read More
LONDON (Alliance News) - Pfizer Inc.'s Chief Executive Officer Ian Read said that the company's proposed takeover of British drug maker AstraZeneca PLC would be a "win-win" for society and shareholders. In a series of videos posted on Pfizer's website, Ian Read said that the deal would libe Read More
LONDON (Alliance News) - Pfizer Inc.'s Chief Executive Officer Ian Read said that the company's proposed takeover of British drug maker AstraZeneca PLC would be a "win-win" for society and shareholders. In a series of videos posted on Pfizer's website, Ian Read said that the deal would libe Read More
LONDON (Alliance News) - Oil and gas services company<strong> Petrofac</strong> Friday issued a profit warning after it said the planned development of the Greater Stella Area oil field in the North Sea would be delayed until next spring, it was hit by low output at a Romanian oil field, and w Read More
LONDON (Alliance News) - Shareholders in Viagra maker Pfizer Inc could take a tax hit if its proposed takeover of UK pharmaceutical giant AstraZeneca goes through, the Wall Street Journal reported, as it separately emerged a key British medical research body had written to the UK government sayin Read More
LONDON (Alliance News) - British gas parent <strong>Centrica</strong> has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians Read More